Trial site
Centre Hospitalier Alpes Leman
Contamine-sur-Arve, 74130, FranceNot linked to an institution yet
- 13running trials
- 3closed trials
The trials here
What the 16 trials at this site are about, from their registry records.
- Phase
- Phase 38 trials
- Phase 26 trials
- Status
- Active, not recruiting8 trials
- Not yet recruiting3 trials
- Completed2 trials
- Enrolling by invitation1 trial
- Recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Intergroupe Francophone de Cancerologie Thoracique4 trials
- UNICANCER3 trials
- ARCAGY/ GINECO GROUP1 trial
- Assistance Publique Hopitaux De Paris1 trial
- Canadian Cancer Trials Group1 trial
- and 6 more
Running trials
Not yet recruiting
Aspirin in Acute Pneumonia in the Elderly: a Multicenter, Double-blind, Randomized, Placebo-controlled Trial.
NCT06774846· Phase 3· Centre Hospitalier Universitaire Dijon· Source
Not yet recruiting
OBINUSS - A trial to evaluate a new drug in systemic sclerosis: obinutuzumab.
2025-524003-68-00· Phase 2· Assistance Publique Hopitaux De Paris· Source
Recruiting
Detecting Tumor DNA in the Blood of HR+/HER2-low Metastatic Breast Cancer Patients to Find Candidates for T-DXd Therapy
NCT06680596· Phase 2· UNICANCER· Source
Enrolling by invitation
ESCAPE10: Epidemiology, Risk Factors, and Outcomes of Severe Community-acquired Pneumonia in Elderly Patients Acquired Pneumonia in Elderly Patients
NCT07070284· Joan Sabater-Riera· Source
Recruiting
Utility of Adjusting Chemotherapy Dose & Dosing Schedule With the SALVage Weekly Dose-dense Regimen in Patients With Poor Prognostic OVARian Cancers Based on the Tumor Unfavorable Primary Chemosensitivity and Incomplete Debulking Surgery
NCT06476184· Phase 3· ARCAGY/ GINECO GROUP· Source
Contact: Mansour RASTKHAH
Active, not recruiting
Durvalumab Plus Etoposide-free Chemotherapy in First-line Treatment of Extensive-disease Small-sell Lung Cancer (SCLC)
NCT05856695· Phase 2· Intergroupe Francophone de Cancerologie Thoracique· Source
Active, not recruiting
Screening for High Frequency Malignant Disease
NCT05117840· Guardant Health, Inc.· Source
Active, not recruiting
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
NCT05156281· Phase 3· Novartis Pharmaceuticals· Source
Active, not recruiting
ENCOrafenib With Binimetinib in bRAF NSCLC
NCT04526782· Phase 2· Intergroupe Francophone de Cancerologie Thoracique· Source
Active, not recruiting
Atezolizumab in Elderly Patients With Advanced Non-Small-Cell Lung Cancer and Receiving Carboplatin Paclitaxel Chemotherapy
NCT03977194· Phase 3· Intergroupe Francophone de Cancerologie Thoracique· Source
Active, not recruiting
Maintaining or Stopping Immunosuppressive Therapy in Patients With ANCA Vasculitis and End-stage Renal Disease
NCT03323476· Phase 3· Centre Hospitalier Departemental Vendee· Source
Active, not recruiting
PRODIGE 34 - ADAGE: Randomised phase III study evaluating adjuvant chemotherapy after resection of stage III colon adenocarcinoma in patients aged 70 and older
NCT02355379· Phase 2· Fondation Franc.Cancerologie Digestive· Source
Active, not recruiting
A Phase III Study for Patients With Metastatic Hormone-naïve Prostate Cancer
NCT01957436· Phase 3· UNICANCER· Source
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Report an error